Phaos Technology Holdings (Cayman) (POAS) Non-Current Debt (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Non-Current Debt came in at $38458.4 in Q4 2025, down 34.4% on a QoQ basis from $58625.9 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Non-Current Debt (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Non-Current Debt data on file, last reported at $38458.4 in Q4 2025.
- Quarterly Non-Current Debt changed N/A year-over-year to $38458.4 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $38458.4 (changed N/A YoY) and the FY2025 annual result came in at $58679.5, down 41.01% from the prior year.
- Non-Current Debt slipped to $38458.4 in Q4 2025, from $58625.9 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $99477.0 in Q2 2024 to a low of $38458.4 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 4.13 Mn | 4.08 Mn | - | 38,458.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 38,458.43 |
| Apr 30, 2025 | 58,625.85 |
| Apr 30, 2024 | 99,477.04 |